Dalcetrapib is a rhCETP inhibitor with IC50 of 0.2 M that increases the plasma HDL cholesterol.
For research use only. We do not sell to patients.
Name | Dalcetrapib |
---|---|
Iupac Chemical Name | S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate |
Synonyms | JTT-705 ; RO-4607381 ; JTT705 ; JTT 705 ; RO 4607381 ; RO4607381 ; Dalcetrapib |
Molecular Formula | C23H35NO2S |
Molecular Weight | 389.595 |
Smile | CC(C)C(SC1=CC=CC=C1NC(C2(CC(CC)CC)CCCCC2)=O)=O |
InChiKey | YZQLWPMZQVHJED-UHFFFAOYSA-N |
InChi | InChI=1S/C23H35NO2S/c1-5-18(6-2)16-23(14-10-7-11-15-23)22(26)24-19-12-8-9-13-20(19)27-21(25)17(3)4/h8-9,12-13,17-18H,5-7,10-11,14-16H2,1-4H3,(H,24,26) |
CAS Number | 211513-37-0 |
Related CAS | 211513-37-0 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | 98% |
Storage | -20 ºC for 3 years |
Solubility | Soluble in DMSO |
Handling | Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation. |
Shipping Condition | Shipped under ambient temperature |
HS Code | 2933999701 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |